Tianlong launched a campaign to care for SMA children

XI’AN China, July 14, 2022 /PRNewswire/ — Tianlong has launched a campaign together with the Spinal muscular atrophy (SMA) care center in China (a non-profit organization for SMA), and The Second Affiliated Hospital of Xi’an Jiaotong University to care for children with SMA in May 2022.

Spinal muscular atrophy (SMA) is an inherited disease that affects nerves and muscles, causing muscles to become increasingly weak. It mostly affects infants and children but can also develop in adults, ranking as the first fatal genetic disease of infants.

Tianlong always bears social responsibility and strives for making more people know about the disease and helping with early detection. We want to make the world of SMA children full of love with deeds. During the campaign, we invited many families in Xi’an, China to join us to accompany SMA children one day. We have also invited a professor to give a lecture on SMA treatment and help answer concerns from parents.

As a leading molecular diagnosis products manufacturer in China, Tianlong has PCR reagents covering 200 kinds of disease detection, including SMA detection. Based on the PCR melting curve method, Tianlong’s Human Survival Motor Neuron 1 (SMN1) Gene Detection Kit is suitable for the auxiliary diagnosis of SMN1 patients and screening of SMN1 gene carriers. Besides PCR reagents, Tianlong can provide an integrated PCR lab solution from the nucleic acid extractor, and PCR systems to compatible reagents. We have helped over 80 countries in building up healthcare systems in the COVID-19 phase. Our Nucleic acid extractors and PCR machines have been a star in the war against COVID-19.

Every child is a gift to parents. They need to be nurtured with full love. Early detection can help with early diagnosis and treatment. We hope more people know about the rare disease and more SMA children and their families can be seen. We will bring technology to life and provide more solutions to better care for people globally.

Explore Tianlong : https://www.tlgenetech.cn/

Follow us on:

LinkedIn: https://www.linkedin.com/company/tianlongbiotech

Facebook:https://www.facebook.com/TianlongBiotech/

Twitter:https://twitter.com/TianlongBiotech

Contact us:

inquiry@medtl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/tianlong-launched-a-campaign-to-care-for-sma-children-301586481.html

SOURCE Xi’an TianLong Science and Technology Co., Ltd

Staff

Recent Posts

American College of Osteopathic Family Physicians Announces 2024-2025 Board of Governors

CHICAGO, IL / ACCESSWIRE / April 3, 2024 / The American College of Osteopathic Family…

3 hours ago

ACOFP Foundation Announces New Campaign, Family Medicine Forward

Campaign underscores the urgency and need to support early career osteopathic family physicians.CHICAGO, IL /…

6 hours ago

Reveal Lasers Reports First Quarter With Record-Breaking 300% Growth

LAS VEGAS, NV / ACCESSWIRE / April 3, 2024 / Reveal Lasers, a burgeoning force…

9 hours ago

Weave Enhances Integration with DrChrono by EverHealth

Deeper integration unlocks powerful Weave features to improve patient experiencesLEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a…

12 hours ago

Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature

CAMBRIDGE, MA / ACCESSWIRE / April 3, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that…

12 hours ago

LPW Training Services Awarded the Association for Talent Development’s Excellence in Practice for 2024

SOMERVILLE, NJ / ACCESSWIRE / April 3, 2024 / LPW Training Services, a global industry…

12 hours ago